{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:20:30Z","timestamp":1784967630757,"version":"3.55.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/bor.0000000000000229","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:33:24Z","timestamp":1448382804000},"page":"21-28","source":"Crossref","is-referenced-by-count":30,"title":["Management of primary and secondary central nervous system vasculitis"],"prefix":"10.1097","volume":"28","author":[{"given":"Carlo","family":"Salvarani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G.","family":"Hunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(12)60069-5","article-title":"Adult primary central nervous system vasculitis.","volume":"380","author":"Salvarani","year":"2012","journal-title":"Lancet"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/BOR.0b013e32834d6d76","article-title":"Adult primary central nervous system vasculitis: an update.","volume":"24","author":"Salvarani","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1212\/01.wnl.0000314687.69681.24","article-title":"Primary CNS vasculitis with spinal cord involvement.","volume":"70","author":"Salvarani","year":"2008","journal-title":"Neurology"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.22359","article-title":"Giant cell arteritis: involvement of intracranial arteries.","volume":"55","author":"Salvarani","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00401-012-0973-9","article-title":"Primary central nervous system vasculitis: pathology and mechanisms.","volume":"123","author":"Giannini","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1212\/WNL.39.2.167","article-title":"Diagnosis and management of islolated angiitis of the central nervous system.","volume":"39","author":"Moore","year":"1989","journal-title":"Neurology"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","article-title":"Primary central nervous system vasculitis: analysis of 101 patients.","volume":"62","author":"Salvarani","year":"2007","journal-title":"Ann Neurol"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MD.0b013e31818896e1","article-title":"Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels.","volume":"87","author":"Salvarani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/art.23300","article-title":"Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome.","volume":"58","author":"Salvarani","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/rheumatology\/ken328","article-title":"Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.","volume":"47","author":"Salvarani","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/rheumatology\/keq303","article-title":"Rapidly progressive primary central nervous system vasculitis.","volume":"50","author":"Salvarani","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1002\/art.30594","article-title":"Primary central nervous system vasculitis presenting with intracranial hemorrhage.","volume":"63","author":"Salvarani","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"Suppl 82","key":"R13-6-20210128","first-page":"S3","article-title":"Catastrophic primary central nervous system vasculitis.","volume":"32","author":"Salvarani","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9343(83)91125-7","article-title":"Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience.","volume":"74","author":"Cupps","year":"1983","journal-title":"Am J Med"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/art.39068","article-title":"Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients.","volume":"67","author":"Salvarani","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/art.38340","article-title":"French Vasculitis Study Group and the French NeuroVascular Society. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system.","volume":"66","author":"De Boysson","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/WNL.0b013e3182a9f545","article-title":"A-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis.","volume":"81","author":"Salvarani","year":"2013","journal-title":"Neurology"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.23337","article-title":"Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment.","volume":"59","author":"Salvarani","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3899\/jrheum.130529","article-title":"Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature.","volume":"40","author":"De Boysson","year":"2013","journal-title":"J Rheumatol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000000293","article-title":"3rd, et al. Treatment of primary central nervous system vasculitis with rituximab: case report.","volume":"82","author":"Salvarani","year":"2014","journal-title":"Neurology"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2015.02.008","article-title":"Mycophenolate mofetil in primary central nervous system vasculitis.","volume":"45","author":"Salvarani","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S1474-4422(10)70243-X","article-title":"Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study.","volume":"9","author":"Hutchinson","year":"2010","journal-title":"Lancet Neurol"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/kep453","article-title":"Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil.","volume":"49","author":"Sen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegeners granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"R26-6-20210128","first-page":"541","article-title":"Severe CNS manifestations as the clinical hallmark in generalized Wegeners granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA): a report of 3 cases and a review of the literature.","volume":"19","author":"Reinhold-Keller","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R29-6-20210128","first-page":"759","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature.","volume":"28","author":"Ghinoi","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis.","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1148\/radiology.213.3.r99dc11794","article-title":"Wegener granulomatosis: MR imaging findings in brain and meninges.","volume":"213","author":"Murphy","year":"1999","journal-title":"Radiology"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/039463201202500431","article-title":"Meningeal involvement in Wegener granulomatosis: case report and review of the literature.","volume":"25","author":"Soriano","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients.","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","article-title":"BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.","volume":"46","author":"Lapraik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0248-8663(03)00266-2","article-title":"Incidence and presentation of the central neurological manifestations of Wegeners granulomatosis: a monocentric study of 14 cases.","volume":"25","author":"Konate","year":"2004","journal-title":"Rev Med Intern"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wagener granulomatosis.","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine"},{"key":"R39-6-20210128","first-page":"20","article-title":"Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment.","volume":"7","author":"Guillevin","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis.","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes.","volume":"54","author":"De","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2014.03.002","article-title":"Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegeners). Results of a single-center cohort study on 66 patients.","volume":"50","author":"Calich","year":"2014","journal-title":"J Autoimmun"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegeners granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar4313","article-title":"Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).","volume":"15","author":"Thiel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10067-009-1291-z","article-title":"Successful treatment of hypertrophic pachymeningitis in refractory Wegeners granulomatosis with rituximab.","volume":"29","author":"Sharma","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2169\/internalmedicine.46.6156","article-title":"Two cases of refractory Wegeners granulomatosis successfully treated with rituximab.","volume":"46","author":"Tamura","year":"2007","journal-title":"Intern Med"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.2005.043885","article-title":"Successful treatment of meningeal involvement in Wegeners granulomatosis with infliximab.","volume":"65","author":"Hermann","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4081\/reumatismo.2013.90","article-title":"Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide.","volume":"65","author":"Benucci","year":"2013","journal-title":"Reumatismo"},{"key":"R50-6-20210128","first-page":"900","article-title":"Refractory Wegeners meningitis treated with rituximab.","volume":"34","author":"Bawa","year":"2007","journal-title":"J Rheumatol"},{"key":"R51-6-20210128","first-page":"1471","article-title":"Recovery from multiple cranial nerve palsy of Wegeners granulomatosis with infliximab.","volume":"35","author":"Fujikawa","year":"2008","journal-title":"J Rheumatol"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/ard.2009.109850","article-title":"Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement.","volume":"69","author":"Saech","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R53-6-20210128","first-page":"S118","article-title":"Rituximab for ANCA-associated vasculitides.","volume":"32","author":"Guillevin","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R54-6-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegeners granulomatosis.","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rdc.2010.05.008","article-title":"Clinical manifestations and treatment of Wegeners granulomatosis.","volume":"36","author":"Holle","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R56-6-20210128","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R57-6-20210128","first-page":"S63","article-title":"Infliximab or rituximab for refractory Wegeners granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.","volume":"29","author":"de MM, Cohen","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R58-6-20210128","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"issue":"Pt 11","key":"R59-6-20210128","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Behcets disease: evaluation of 200 patients. The Neuro-Behcet Study Group.","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"R60-6-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","article-title":"Neurological manifestations of Behcets disease: evaluation of 40 patients treated by cyclophosphamide.","volume":"168","author":"Ait Ben Haddou","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"R61-6-20210128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/pmj.76.900.629","article-title":"Behcets disease.","volume":"76","author":"Kontogiannis","year":"2000","journal-title":"Postgrad Med J"},{"key":"R62-6-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","article-title":"Behcets syndrome and the nervous system.","volume":"17","author":"Siva","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R63-6-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","article-title":"Infliximab for the treatment of Neuro-Behcets disease: a case series and review of the literature.","volume":"59","author":"Pipitone","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R64-6-20210128","first-page":"119","article-title":"Treatment of neuro-Behcets disease with infliximab. An international multicentre case-series of 18 patients.","volume":"28","author":"Al-Araji","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R65-6-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Behcets disease: analysis of published data on 369 patients.","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R66-6-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Behcets disease.","volume":"111","author":"Borhani","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"R67-6-20210128","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-6-20210128","first-page":"S73","article-title":"Refractory neuro-Behcet treated by tocilizumab: a case report.","volume":"30","author":"Urbaniak","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R69-6-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","article-title":"Tocilizumab treatment for neuro-Behcets disease, the first report.","volume":"114","author":"Shapiro","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"R70-6-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","article-title":"Tocilizumab for severe refractory neuro-Behcet: three cases IL-6 blockade in neuro-Behcet.","volume":"44","author":"Addimanda","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R71-6-20210128","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00296-013-2814-0","article-title":"Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis.","volume":"33","author":"Zenone","year":"2013","journal-title":"Rheumatol Int"},{"key":"R72-6-20210128","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.3174\/ajnr.A2763","article-title":"Infarction of the corpus callosum: a manifestation of giant cell arteritis.","volume":"32","author":"Lempel","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"R73-6-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.autrev.2013.10.001","article-title":"Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.","volume":"13","author":"Samson","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R74-6-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.10922","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.","volume":"49","author":"Guillevin","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:24Z","timestamp":1620948864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201601000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000229","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}